Which Weight Management Treatment Suits You Best?
Is Wegovy or Mounjaro Better for UK Availability and Stock?
The question of whether Wegovy or Mounjaro is better often depends on practical factors like availability and reliable supply. EverydayMeds maintains consistent stock levels of both treatments, ensuring you won't face the supply disruptions that have historically affected Wegovy availability across the UK. Our direct partnership with Novo Nordisk ensures authentic Wegovy stock across all five doses, from the 0.25mg starter through to 2.4mg maintenance pens. While both treatments require the same cold-chain delivery and clinical oversight, Wegovy's superior room temperature stability—6 weeks versus Mounjaro's 21 days—makes it more practical for UK lifestyles.
When comparing whether Wegovy or Mounjaro is better for immediate availability, our order processing speaks volumes about reliability. Orders placed before 2pm typically receive prescriber approval within 24 hours using our express service, with next-day delivery maintaining the crucial 2-8°C temperature requirements. This consistent availability eliminates the anxiety many patients have experienced when their preferred treatment suddenly becomes unavailable, allowing you to focus on your weight management journey rather than supply concerns.
Comparing Wegovy vs Mounjaro Pricing and Value in the UK
Determining whether Wegovy or Mounjaro is better value requires understanding the complete cost structure of each treatment. Wegovy pricing at EverydayMeds starts at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the maintenance 2.4mg dose—all after applying discount code FIRST40 for new customers or DOSE25 for returning patients at checkout. Our bundle options provide additional convenience, with the Intro Duo (0.25mg and 0.5mg together) available for £169.99, ensuring you have your first two months of treatment secured in one order.
While Mounjaro follows a different pricing structure, the question of whether Wegovy or Mounjaro offers better value extends beyond simple cost comparison. Wegovy's established clinical evidence from the STEP trial programme, combined with NICE approval under TA875, provides confidence in long-term cost-effectiveness. The treatment's storage advantages also reduce waste—Wegovy pens can survive 6 weeks at room temperature if accidentally left out, whereas Mounjaro requires replacement after 21 days, potentially adding unexpected costs to your treatment journey.
Clinical Evidence: Is Wegovy or Mounjaro Better Supported by Research?
When evaluating whether Wegovy or Mounjaro is better from a clinical perspective, both treatments have demonstrated significant efficacy in their respective trial programmes. Wegovy's STEP clinical trials showed that patients achieved approximately 15% average weight loss at 68 weeks when combined with reduced-calorie diet and increased physical activity, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The recent SELECT cardiovascular outcomes trial further demonstrated a 20% reduction in major adverse cardiovascular events, adding an important safety dimension to the efficacy profile.
However, directly comparing trial outcomes to determine whether Wegovy or Mounjaro is better would be misleading, as the studies used different patient populations, trial designs, and endpoints. What matters more is that both treatments represent evidence-based approaches to weight management, each working through distinct but complementary mechanisms. Your prescriber can evaluate which treatment's clinical profile aligns best with your individual health circumstances, medical history, and weight management goals.
How Wegovy Works: Understanding the GLP-1 Mechanism
Understanding whether Wegovy or Mounjaro is better requires grasping how each treatment works in your body. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural fullness hormone your intestines produce after eating. When you inject Wegovy once weekly using the FlexTouch pen, it binds to GLP-1 receptors in your brain's appetite centres, promoting feelings of satiety and reducing food cravings between meals. This mechanism helps you feel satisfied with smaller portions while reducing the psychological drive to eat that often sabotages traditional diet approaches. The treatment also slows gastric emptying, meaning food stays in your stomach longer, contributing to prolonged feelings of fullness that support adherence to reduced-calorie eating plans.
Streamlined Ordering: Getting Your Prescribed Treatment Quickly
Deciding whether Wegovy or Mounjaro is better becomes academic if you can't access your chosen treatment promptly and reliably. EverydayMeds streamlines this process through our comprehensive 3-minute online clinical assessment, covering your medical history, current medications, weight management goals, and any contraindications that might affect treatment suitability. Once submitted, our UK-registered prescribers review your assessment within 3 working days as standard, or within 24 hours if you select our express service for urgent treatment needs. Following approval, your prescribed treatment ships via next-day delivery using specialised cold-chain packaging that maintains the crucial 2-8°C temperature throughout transit, ensuring your medication arrives in perfect condition. This reliable process means you can focus on your treatment journey rather than worrying about supply interruptions or delivery delays that might compromise your progress.
Storage and Practical Considerations: Wegovy's Real-World Advantages
The practical question of whether Wegovy or Mounjaro is better often comes down to real-world usability and storage convenience. Wegovy demonstrates clear advantages in temperature stability—while both treatments must be stored in the fridge at 2-8°C before first use, Wegovy remains stable for up to 6 weeks at room temperature (below 30°C) once removed from refrigeration. This extended stability proves invaluable for UK lifestyles involving business travel, holidays, or simply the occasional oversight of leaving your pen out overnight. Mounjaro's 21-day room temperature limit requires more vigilant storage management and may result in costly medication replacement if accidentally left at room temperature too long. The FlexTouch pen delivery system used by Wegovy also provides reliable, consistent dosing with clear dose escalation from 0.25mg through to 2.4mg maintenance, following a proven schedule that minimises side effects while maximising therapeutic benefit.
Why Stock Availability Matters When Choosing Between Treatments
The historical question of whether Wegovy or Mounjaro is better has often been overshadowed by simple availability—you can't benefit from the ideal treatment if it's out of stock when you need it. EverydayMeds addresses this fundamental challenge by maintaining robust inventory levels across all Wegovy doses, backed by direct supply agreements with Novo Nordisk that ensure consistent availability even during periods of high demand. Our inventory management systems track usage patterns and automatically reorder stock before depletion, meaning you'll never face treatment interruptions due to supply issues.
This reliable availability extends to our bundle offerings, where you can secure multiple doses simultaneously rather than hoping individual pens remain in stock when you need your next dose escalation. The Gentle Start Trio, containing two 0.25mg pens plus one 0.5mg pen for £269.99, ensures you can begin and progress your treatment without supply anxiety—a crucial consideration when treatment interruptions can affect both efficacy and side effect management during dose escalation phases.
Making Your Decision: Professional Guidance and Immediate Access
Rather than definitively answering whether Wegovy or Mounjaro is better, the most important step is securing professional medical guidance while knowing your chosen treatment is immediately available. At EverydayMeds, our clinical team evaluates your individual circumstances during the prescribing assessment, considering factors like your medical history, current medications, lifestyle requirements, and specific weight management goals that influence treatment suitability. Both treatments are available in stock and ready for next-day dispatch once prescribed, eliminating the supply uncertainty that has historically complicated treatment decisions. New customers can apply discount code FIRST40 at checkout, while returning customers use DOSE25, ensuring transparent pricing alongside reliable supply. Our GPhC registration (#9012878) ensures you're receiving authentic, properly stored medication through a fully regulated UK pharmacy service, giving you confidence in both treatment quality and ongoing support throughout your weight management journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
